Tachykinin NK-1 receptor probed with constrained analogues of substance P

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 12, 1996, Pages 2167-2178

  Sagan, Sandrine ^a   Josien, Hubert ^a   Karoyan, Philippe ^a   Brunissen, Alié ^a   Chassaing, Gérard ^a   Lavielle, Solange ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CYCLIC AMP; INOSITOL PHOSPHATE; NEUROKININ 1 RECEPTOR; RECEPTOR SUBTYPE; SUBSTANCE P; SUBSTANCE P DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOASSAY; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOMER; GUINEA PIG; HUMAN; ILEUM; NONHUMAN; PROTEIN FOLDING; STEREOISOMERISM;

ANALGESICS; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; GUINEA PIGS; HUMANS; ILEUM; INDOLES; MALE; PHOSPHATIDYLINOSITOLS; RECEPTORS, NEUROKININ-1; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE P; TRANSFECTION;

EID: 0030465953     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(96)00230-1     Document Type: Article

References (37)

1. 1. Hruby, V. J.; Toth, G.; Gehrig, C. A.; Kao, L. F.; Knapp, R.; Lui, G. K.; Yamamura, H. I.; Kramer, H. T.; Davies, P.; Burks, T. F. J. Med. Chem. 1991, 34, 1823.
2. 2. Mosberg, H. I.; Kroona, H. B. J. Med. Chem. 1992, 35, 4498.
3. 3. Toth, G.; Russell, K. C.; Landis, G.; Kramer, T. H.; Fang, L.; Knapp, R.; Davies, P.; Burks, T. F.; Yamamura, H. I.; Hruby, V. J. J. Med. Chem. 1992, 55, 2384.
4. 4. Kazmierski, W.; Wire, S. W.; Lui G. K.; Knapp, R. J.; Shook, J. E.; Burks, T. F.; Yamamura, H. I.; Hruby, V. J. J. Med. Chem. 1988, 31, 2170.
5. 5. Hsieh, K. H.; Lahann, T. R.; Speth, R. C. J. Med. Chem. 1989, 32, 898.
6. 6. Haskell-Luevano, C.; Boteju, L. W.; Mina, H.; Dickinson, C.; Gantz, I.; Yamada, T.; Hadley, M. E.; Hruby, V. J. J. Med. Chem. 1995, 38, 4720.
7. 7. Josien, H.; Lavielle, S.; Brunissen, A.; Saffroy, M.; Torrens, Y.; Beaujouan, J.-C.; Glowinski, J.; Chassaing, G. J. Med. Chem. 1994, 37, 1586.
8. 8. Petitet, F.; Saffroy, M.; Torrens, Y.; Lavielle, S.; Chassaing, G.; Loeuillet, D.; Glowinski, J.; Beaujouan, J.-C. Peptides 1992, 13, 383.
9. 9. Hall, J.; Mitchell, D.; Morton, I. K. M. Br. J. Pharmacol. 1994, 112, 985.
10. 10. Maggi, C. A.; Patacchini, R.; Meini, S.; Quartara, L.; Sisto, A.; Potier, E.; Guiliani, S.; Giachetti, A. Br. J. Pharmacol. 1994, 112, 150.
11. 11. Zeng, X. P.; Burcher, E. J. Pharm. Exp. Ther. 1994, 270, 1295.
12. 12. Noda, K.; Shimohigashi, Y.; Izumiya, N. In The Peptides: Analysis, Synthesis, Biology; Gross. E.; Meienhofer, J., Eds.; Academic Press: New York, 1983; Vol. 5, pp 285-339.
13. 13. Nitz, T. J.; Shimohigashi, Y.; Costa, T.; Chen, H. C.; Stammer, C. Int. J. Peptide Protein Res. 1986, 27, 522.
14. 14. Chassaing, G.; Lavielle, S.; Julien, S.; Marquet, A. Tetrahedron Lett. 1985, 26, 623.
15. 15. Sagan, S.; Chassaing, G.; Pradier, L.; Lavielle, S. J. Pharm. Exp. Ther. 1996, 276, 1039.
16. 16. Beaujouan, J. C.; Heuillet, E.; Petitet, F.; Saffroy, M.; Torrens, Y.; Glowinski, J. Br. J. Pharmacol. 1993, 108, 793.
17. 17. Cheng, Y.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22, 3099.
18. 18. Bradford, M. Anal. Biochem. 1976, 72, 248.
19. 19. Torrens, Y.; Daguet de Montety, M.-C.; El Etr, M.; Beaujouan, J.-C.; Glowinski, J. J. Neurochem. 1989, 52, 1913.
20. 20. Nakajima, Y.; Tsuchida, K.; Negishi, M.; Ito, S.; Nakanishi, S. J. Biol. Chem. 1992, 267, 2437.
21. 21. Munson, P. J.; Rodbar, D. Anal. Biochem. 1980, 107, 220.
22. 22. Chassaing, G.; Convert, O.; Lavielle, S. Eur. J. Biochem. 1986, 154, 77.
23. 23. Lavielle, S.; Chassaing, G.; Loeuillet, D.; Convert, O.; Torrens, Y.; Beaujouan, J.-C.; Saffroy, M.; Petitet, F.; Bergström, L.; Glowinski, J. Fundam. Clin. Pharmacol. 1990, 4, 257.
24. 24. Duplaa, H.; Chassaing, G.; Lavielle, S.; Beaujouan, J.-C.; Torrens, Y.; Saffroy, M.; Glowinski, J.; D'Orléans-Juste, P.; Regoli, D.; Carruette, A.; Garret, C. Neuropeptides 1991, 19, 259.
25. 25. Trump-Kallmeyer, S.; Hoflack, J.; Hibert, M. F. In The Tachykinin Receptors; Buck, S. H., Ed.; Humana Press, Totowa, New Jersey, 1994; pp 237-255.
26. 26. Li, Y. M.; Maenerakis, M.; Stimson, E. R.; Maggio, J. E. J. Biol. Chem. 1995, 270, 1213.
27. 27. Boyd, N. D.; Kage, R.; Dumas, J. J.; Krause, J. E.; Leeman, S. E. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 433.
28. 28. Girault, S.; Sagan, S.; Bolbach, G.; Lavielle, S.; Chassaing, G. Eur. J. Biochem. 1996, 240, 215.
29. 29. Josien, H.; Convert, O.; Berlose, J.-P.; Sagan, S.; Brunissen, A.; Lavielle, S.; Chassaing, G. Biopolymers 1996, in press.
30. 30. Garret, C.; Carruette, A.; Fardin, V.; Moussaoui, S.; Peyronel, J.-F.; Blanchard, J.-C.; Laduron, P. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 10208.
31. 31. Kenakin, T. Trends Pharmacol. Sci. 1995, 16, 232.
32. 32. Fong, T. M.; Anderson, S. A.; Yu, H.; Huang, R. R. C.; Strader, C. Mol. Pharmacol. 1991, 41, 24.
33. 33. Kage, R.; Leeman, S.; Boyd, N. E. J. J. Neurochem. 1993, 60, 347.
34. 34. Mantyh, P. W.; Rogers, S. D.; Ghilardi, J. R.; Maggio, J. E.; Mantyh, C. R.; Vigna, S. R. Brain Res. 1996, 719, 8.
35. 35. Arunlakshama, O.; Schild, H. O. Br. J. Pharmacol. 1959, 14, 48.
36. 36. Kenakin, T. In Pharmacological Analysis of Drug-Receptor Interaction, 2nd ed.; Raven Press, New York, 1993; pp 214-222.
37. 37. Carruette, A.; Moussaoui, S. M.; Champion, A.; Cottez, D.; Goniot, P.; Garret, C. Neuropeptides 1991, 19, 91.